![]() |
|
|
Palladin Institute of Biochemistry, Kiev, Ukraine (M.V.S., E.N.K., L.N.K.); Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Moscow, Russia (V.I.T., Y.N.U.); and Institut Pasteur, Paris, France (J.P.C., R.G.)
Nicotine has been shown to affect B lymphocyte immune response. In this study, we have explored the presence of nicotinic receptors in B lymphocyte-derived cell lines, myeloma X63-Ag8 and hybridoma 1D6. We found that myeloma expressed on average 10,170 ± 1,100 [3H]epibatidine and 6,730 ± 370 125I-
-bungarotoxin binding sites per cell, thus reflecting the presence of both homomeric and heteromeric nicotinic receptors. More specifically, the presence of
4- and
7-containing nicotinic receptor subunits was demonstrated in both myeloma and hybridoma cells with subunit-specific antibodies. It was significantly higher in dividing than in resting cells. Long-term exposure to nicotine, at physiological concentration found in smokers, resulted in up-regulation of both
4 and
7 subunits in hybridoma cells. Additionally, nicotine stimulated hybridoma cell proliferation, whereas it decreased antibody production. In contrast,
7-specific snake toxins inhibited cell proliferation but increased antibody production. It is concluded that myeloma and hybridoma cells express
4- and
7-containing nicotinic receptors, which participate in regulating cell proliferation and function.
Address correspondence to: Dr. Marina V. Skok, Palladin Institute of Biochemistry, 9 Leontovicha Str., 01030 Kiev, Ukraine. E-mail: skok{at}biochem.kiev.ua
This article has been cited by other articles:
![]() |
I. Cloez-Tayarani and J.-P. Changeux Nicotine and serotonin in immune regulation and inflammatory processes: a perspective J. Leukoc. Biol., March 1, 2007; 81(3): 599 - 606. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Cormier, Y. Paas, R. Zini, J.-P. Tillement, G. Lagrue, J.-P. Changeux, and R. Grailhe Long-Term Exposure to Nicotine Modulates the Level and Activity of Acetylcholine Receptors in White Blood Cells of Smokers and Model Mice Mol. Pharmacol., December 1, 2004; 66(6): 1712 - 1718. [Abstract] [Full Text] [PDF] |
||||